Literature DB >> 31825316

Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency.

G Tessarin1, M P Bondioni2, S Rossi1, L Palumbo3, A Soresina3, R Badolato1, A Plebani1, V Lougaris1.   

Abstract

Entities:  

Keywords:  B cell; Common variable immunodeficiency; Granulomatous lymphocytic interstitial lung disease; Rituximab; Tertiary lymphoid structures

Mesh：

Substances：

Year:  2019        PMID： 31825316     DOI： 10.18176/jiaci.0450

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  4 in total

1.  What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review.

Authors:  Astrid C van Stigt; Willem A Dik; Lieke S J Kamphuis; Bas M Smits; Joris M van Montfrans; P Martin van Hagen; Virgil A S H Dalm; Hanna IJspeert
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

2.  Interstitial Lung Disease in Common Variable Immunodeficiency.

Authors:  Joao Pedro Lopes; Hsi-En Ho; Charlotte Cunningham-Rundles
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

3.  Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey.

Authors:  Annick A J M van de Ven; Tiago M Alfaro; Alexandra Robinson; Ulrich Baumann; Anne Bergeron; Siobhan O Burns; Alison M Condliffe; Børre Fevang; Andrew R Gennery; Filomeen Haerynck; Joseph Jacob; Stephen Jolles; Marion Malphettes; Véronique Meignin; Tomas Milota; Joris van Montfrans; Antje Prasse; Isabella Quinti; Elisabetta Renzoni; Daiana Stolz; Klaus Warnatz; John R Hurst
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

4.  Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.

Authors:  Olivia A C Lamers; Bas M Smits; Helen Louisa Leavis; Godelieve J de Bree; Charlotte Cunningham-Rundles; Virgil A S H Dalm; Hsi-En Ho; John R Hurst; Hanna IJspeert; Sabine M P J Prevaes; Alex Robinson; Astrid C van Stigt; Suzanne Terheggen-Lagro; Annick A J M van de Ven; Klaus Warnatz; Janneke H H M van de Wijgert; Joris van Montfrans
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.